Pharmaceutical companies need to identify individuals that are leaders in their fields of study for various business needs. Pharma terms these individuals “Key Opinion Leaders” (KOLs). In addition to deep expertise in their fields, these KOLs often have influence over the direction of major research themes in a given area of study, access to research funding, and assist in federal and state policy governing these areas. Consequently, companies can gain important strategic insights and influence by identifying KOLs and fostering engagement.
Our team has developed a highly customizable tool that can support pharmaceutical clients in identifying the most impactful Key Opinion Leaders (KOLs) in a given field, disease, or other areas. Our product uses deep learning AI, combined with our industry leading natural language processing (NLP) libraries to extract and synthesize information from publications, social media posts, clinical trials, and other publicly available knowledge sources. This information is then visualized in the profiles and dashboards of those KOLs in a given area of interest. This allows our pharmaceutical clients to quickly screen and identify key individuals for engagement.
